(Total Views: 536)
Posted On: 05/20/2020 9:18:33 PM
Post# of 154120
Old news clip gives some CYDY historical perspective.
Here is a quote from this story that gives some insight into NP.
"CytoDyn is indeed a publicly traded biotech, one with a rocky financial past. After the company managed to dodge bankruptcy in 2008 (that’s when Pourhassan first came on board, shelling out $160,000 of his own money to cover company expenditures the time), the stock peaked at $3.90 in April 2011, and hit a recent low of $0.71 on December 30, 2015. During the weeks leading up to the February 10 Dr. Oz broadcast, the stock generally rose, hitting $1.15 the day of the show. Since then its value has plummeted, and currently sits at $0.76."
Link to the whole story.
https://www.poz.com/article/charlie-sheen-pin...g-hiv-meds
Here is a quote from this story that gives some insight into NP.
"CytoDyn is indeed a publicly traded biotech, one with a rocky financial past. After the company managed to dodge bankruptcy in 2008 (that’s when Pourhassan first came on board, shelling out $160,000 of his own money to cover company expenditures the time), the stock peaked at $3.90 in April 2011, and hit a recent low of $0.71 on December 30, 2015. During the weeks leading up to the February 10 Dr. Oz broadcast, the stock generally rose, hitting $1.15 the day of the show. Since then its value has plummeted, and currently sits at $0.76."
Link to the whole story.
https://www.poz.com/article/charlie-sheen-pin...g-hiv-meds
(0)
(0)
